The Role of Aldosterone and Mineralocorticoid Receptors in Cardiovascular Disease

By Funder John W.  

American Journal of Cardiovascular Drugs, Vol. 7, Iss. 3, 2007-01 ,pp. : 151-157

Adis International

Access to resources Recommend Favorite

Targeting the thyrotropin receptor in thyroid disease

By El-Kaissi Samer   Wall Jack R  

Expert Opinion on Therapeutic Targets, Vol. 16, Iss. 7, 2012-07 ,pp. : 719-727

Informa Healthcare

Access to resources Recommend Favorite

Adenosine receptor targeting in health and disease

By Gessi Stefania   Merighi Stefania   Fazzi Debora   Stefanelli Angela   Varani Katia   Borea Pier Andrea  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 12, 2011-12 ,pp. : 1591-1609

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular and renal effects of central administration of a mineralocorticoid receptor antagonist in conscious female rats

By Rahmouni K.   Barthelmebs M.   Grima M.   Imbs J.L.   De Jong W.  

European Journal of Pharmacology, Vol. 385, Iss. 2, 1999-12 ,pp. : 199-202

Elsevier

Access to resources Recommend Favorite

Targeting platelets for prevention and treatment of cardiovascular disease

By Duhamel Todd A   Xu Yan-Jun   Arneja Amarjit S   Dhalla Naranjan S  

Expert Opinion on Therapeutic Targets, Vol. 11, Iss. 12, 2007-12 ,pp. : 1523-1533

Informa Healthcare

Access to resources Recommend Favorite